Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dóra Hantosi"'
Autor:
Anita Kovács, Dóra Hantosi, Nikoletta Szabó, Annamária Letoha, Csaba Lengyel, Imre Földesi, Katalin Burián, András Palkó, Dániel Veréb, Zsigmond Tamás Kincses
Publikováno v:
PLoS ONE, Vol 19, Iss 1, p e0297023 (2024)
ObjectivesEmerging results indicate that, in COVID-19, thromboembolic complications contribute to the high mortality and morbidity. Previous research showed that the prevalence of pulmonary embolism (PE) is between 25-50% in COVID-19 patients, howeve
Externí odkaz:
https://doaj.org/article/bdc7631742cb42839334d4ea571020c3
Publikováno v:
Biology, Vol 9, Iss 12, p 460 (2020)
Ischemic stroke is a leading cause of death and disability worldwide. Yet, the effective therapy of focal cerebral ischemia has been an unresolved challenge. We propose here that ischemic tissue acidosis, a sensitive metabolic indicator of injury pro
Externí odkaz:
https://doaj.org/article/5381d14e6a484df78b1029d6688b039a
Publikováno v:
Biology, Vol 9, Iss 460, p 460 (2020)
Biology
Biology
Simple Summary Ischemic stroke is caused by the blockade of a blood vessel in the brain. Consequently, the brain region supplied by the blocked vessel suffers brain damage and becomes acidic. Here we provide a summary of the causes and consequences o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::124325f8dfd42ccc7629064c25a66616
https://www.mdpi.com/2079-7737/9/12/460
https://www.mdpi.com/2079-7737/9/12/460
Autor:
Róbert Berkecz, Ákos Menyhárt, Ferenc Bari, Viktória Varga, István A. Krizbai, Írisz Szabó, Ede Frecska, Szabolcs Dvorácskó, Eszter Farkas, Tímea Körmöczi, Nicholas V. Cozzi, Szilvia Kecskés, Rita Frank, Csaba Tömböly, Attila Farkas, Dóra Hantosi
Publikováno v:
Neuropharmacology. 192:108612
Dimethyltryptamine (DMT), an endogenous ligand of sigma-1 receptors (Sig-1Rs), acts against systemic hypoxia, but whether DMT may prevent cerebral ischemic injury is unexplored. Here global forebrain ischemia was created in anesthetized rats and aggr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6e8ff9c265d69e10de574fe714b60e4
https://doi.org/10.1016/j.neuropharm.2021.108612
https://doi.org/10.1016/j.neuropharm.2021.108612
Autor:
Dániel Varga, Orsolya Ivánkovits-Kiss, Eszter Farkas, Ákos Menyhárt, Viktória Varga, Ferenc Bari, Dóra Hantosi, Írisz Szabó, Orsolya Tóth, Imre Dékány, László Janovák
Publikováno v:
Neuropharmacology. 162
Stroke is an important cause of mortality and disability. Treatment options are limited, therefore the progress in this regard is urgently needed. Nimodipine, an L-type voltage-gated calcium channel antagonist dilates cerebral arterioles, but its sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9d500d5db5ff22a2ffee7f032983cc3
https://pubmed.ncbi.nlm.nih.gov/31715193
https://pubmed.ncbi.nlm.nih.gov/31715193
Autor:
Orsolya Tóth, Ibolya Horváth, Ákos Menyhárt, Dániel Varga, Ferenc Bari, Rita Frank, Írisz Szabó, Dóra Hantosi, Zsolt Török, Ákos Hunya, László Vígh, Eszter Farkas
Publikováno v:
Br J Pharmacol
Background and purpose A new class of dihydropyridine derivatives, which act as co-inducers of heat shock protein but are devoid of calcium channel antagonist and vasodilator effects, has recently been developed with the purpose of selectively target
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e05f116afbc586db1c97e9fd03de7c17
https://pubmed.ncbi.nlm.nih.gov/30737967
https://pubmed.ncbi.nlm.nih.gov/30737967